Quest Diagnostics initiated with a Buy at Redburn Atlantic
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
Digi Power Reports 115% Quarterly Revenue Growth in Q1 2025, Maintains Debt-Free Operations and Strengthens Cash Position
The Company’s total aggregate Q1 2025 revenue of approximately $12.1 million (based on a BTC price of $83,500 as of March 31, 2025, per CoinMarketCap) represents an increase in quarterly revenue of ...
Healthline2d
Quest Health Review 2025: No Doctor, No Problem — How to Order Your Own Lab Tests Online
The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...
Le Lézard5d
Partnering for Precision: CDx Development for Antibody-Drug Conjugates, Upcoming Webinar Hosted by Xtalks
As antibody-drug conjugates (ADCs) advance in precision oncology, diagnostics play a vital role in identifying eligible patients, validating biomarkers and supporting regulatory approval. A ...
Barchart on MSN6d
Is Quest Diagnostics Stock Outperforming the S&P 500?
With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...
StockStory.org on MSN6d
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, ...